|
Estimated Time of Completion |
2 hours 30 minutes |
Description / Overview |
This activity is based on the proceedings of a roundtable convened at the Cleveland Clinic on January 17, 2008, by the Cleveland Clinic Journal of Medicine. It examines how and why the management of vasomotor symptoms and other menopause-related health issues should be tailored to the individual woman, based on her assessment of her most bothersome symptom(s) and her personal priorities regarding risks, benefits, and quality of life. |
Objectives |
At the conclusion of this activity, the participant will be able to:
- Compare and contrast new information on the cardiovascular effects of postmenopausal hormone therapy in younger, recently menopausal women as opposed to older, late-postmenopausal women
- Better understand menopausal risk assessment and explain the need to individualize therapy for symptomatic women
- Describe the controversies surrounding menopausal hormone therapy and avoid misapplying data derived from older women to younger women
- Recognize the problem of vasomotor instability in symptomatic peri- and postmenopausal women and the availability of new therapeutic options—both hormonal and nonhormonal—to deal with common menopausal symptoms.
|
Target Audience |
This activity is intended for internists, cardiologists, and other physicians who care for menopausal and postmenopausal women. |
Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2. |
Activity Director |
Holly L. Thacker, MD, FACP
Director, Women’s Health Center, Women’s Health and Breast Pavilion,
OB/GYN & Women’s Health Institute
Associate Professor, Cleveland Clinic Lerner College
of Medicine at Case Western Reserve University
Cleveland Clinic
Cleveland, OH |
Author / Faculty |
Margery Gass, MD; Howard N. Hodis, MD; Marjorie R. Jenkins, MD;
Margaret McKenzie, MD, FACOG; Andrea L. Sikon, MD, FACP |
Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Margery Gass, MD |
| |
Consulting |
Wyeth Pharmaceuticals;
Upsher-Smith; Eli Lilly;
Procter & Gamble; Palatin Technologies; Esprit Pharma; Roche; Merck; Novartis |
| |
| |
Clinical Trial Funding |
Wyeth Pharmaceuticals; Boehringer Ingelheim; Procter & Gamble; Organon; Roche |
| |
| Marjorie R. Jenkins, MD |
| |
Teaching and Speaking |
Pfizer
|
| |
| Holly L. Thacker, MD, FACP |
| |
Teaching
and Speaking |
Procter & Gamble; Sanofi-Aventis; Bayer; Wyeth Pharmaceuticals; Novartis; Esprit Pharma |
The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Howard N. Hodis, MD
Margaret McKenzie, MD, FACOG
Andrea L. Sikon, MD
|
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges
an educational grant for support of this activity from:
Wyeth Pharmaceuticals
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and the Cleveland Clinic Journal of Medicine.
Contact Information | Privacy Policy | Disclaimer
Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.
|